Blood Collection Market - Use of Rfid in The Transfusion Process and Needle-Free Devices resulting Opportunity Growth

1. MarketsandMarkets Presents Blood Collection Market - Use of Rfid in The Transfusion Process and Needle-Free Devices resulting Opportunity Growth http://www.marketsandmarkets.com/Market-Reports/vaccine-adjuvants-market-152603894.html

2. The "Blood Collection Market Product (Syringes, Needles, EDTA, Heparin, Serum, Tubes, Blood Lancets, Blood Bags, Vials), Application (Diagnostic, Treatment, Infectious Diseases, Non Infectious Diseases) & End User (Blood Banks, Hospitals) - Forecast to 2021", report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the Blood Collection market along with the estimates and forecasts of the revenue and market share analysis. Browse: 103market data tables 59figures 156pages And in-depth TOC on “Blood CollectionMarket ” Download The PDF Brochure@ http://www.marketsandmarkets.com/pdfdownload.asp?id=39733117 The blood collection market is expected to reach USD 9.90 Billion by 2021 from USD 7.65 Billion in 2016, at CAGR of 5.3% in the forecast period. http://www.marketsandmarkets.com/Market-Reports/vaccine-adjuvants-market-152603894.html

3. Industry growth is driven by rising incidences of infectious as well as non-infectious diseases, increasing number of surgical procedures, and growing number of trauma and accidental cases are propelling market growth. However, risks associated with blood transfusions in underdeveloped regions is expected to restrain the growth of the blood collection market in the forecast period. Request Sample@ http://www.marketsandmarkets.com/requestsample.asp?id=39733117 The blood collection market is broadly segmented by product, application, end user, and region. On the basis of products, the blood collection market is divided into blood collection needles and syringes, blood collection tubes, blood lancets, blood bags, vials, and others (microscopic slides, slide stainers, and test tube racks, among others).  http://www.marketsandmarkets.com/Market-Reports/vaccine-adjuvants-market-152603894.html

4. On the basis of applications, the blood collection market is bifurcated into diagnostics and treatment applications. The diagnostics segment is further categorized into infectious diseases and non-infectious diseases. The diagnostics segment is expected to account for the largest share of the blood collection market in 2016. On the basis of end users, the blood collection market is segmented into hospitals and diagnostic centers, blood banks, and other end users (emergency medical services, long-term acute care, trauma centers, and nursing homes). The hospitals and diagnostic centers segment is expected to account for the largest share of the blood collection market in 2016. http://www.marketsandmarkets.com/Market-Reports/vaccine-adjuvants-market-152603894.html

5. Geographically, North America is expected to account for the largest share of the blood collection market. The Asia-Pacific region, on the other hand, is expected to witness the highest growth rate in the forecast period. The presence of a large population base coupled with the improving healthcare infrastructure, growing medical tourism, increasing number of hospitals, rising disposable incomes, and emerging markets are expected to offer significant growth opportunities for players operating in the Asia-Pacific blood collection market. The major players in Blood Collectionmarket include Becton, Dickinson and Company (U.S.), Abbott Laboratories (U.S.), Nipro Medical Corporation (Japan), and Terumo Corporation (Japan). http://www.marketsandmarkets.com/Market-Reports/vaccine-adjuvants-market-152603894.html

6. About MarketsandMarkets™ MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve. MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.  http://www.marketsandmarkets.com/Market-Reports/vaccine-adjuvants-market-152603894.html

7. Contact Us Mr. Rohan MarketsandMarkets™ 701 Pike Street Suite 2175, Seattle, WA 98101, United States Tel: 1-888-600-6441 Email: sales@marketsandmarkets.comMarketsandMarkets Bloghttp://www.marketsandmarkets.comhttp://twitter.com/marketsmarkets http://www.linkedin.com/company/marketsandmarkets